Brandon Harvey, Ph.D. - Principal Investigators - The Intramural Research Program of the National Institute on Drug Abuse

Skip Navigation


Dr. Aponte


NIH Bayview Research Center
251 Bayview Boulevard
Suite 200, Room 06A729
Baltimore MD 21224

Voice: 443-740-2590

Brandon Harvey, Ph.D., Principal Investigator

Director, OTTC; Associate Scientist, GNI Lab


Dr. Harvey received his Ph.D. in Neurobiology and Anatomy from the University of Rochester where he began his interest in gene delivery and gene therapy for the central nervous system. He joined NIDA in 2002 where he brought methods for viral vector production to the Neural Protection and Regeneration Section led by Dr. Yun Wang. Dr. Harvey’s experience with molecular biology and viral vectors coupled with his background in the models of neurodegeneration and neurotoxicity contribute to his directorship of the Optogenetics and Transgenic Technology Core where he develops genetic tools for monitoring and manipulating the activity of neurons and glia in the rodent central nervous system. Dr. Harvey also has an ongoing research project as part of the Cellular Protection and Repair (CPR) laboratory examining the protein Mesencephalic Astrocyte Derived Neurotrophic Factor (MANF) and its associated functions in the neuroprotection, ER stress, unfolded protein response (UPR) and the KDEL retrieval pathway.

Selected Publications:

View more publications at PubMed.

More about Dr. Harvey

Health and Human Services Logo National Institute on Drug Abuse Logo

The National Institute on Drug Abuse (NIDA), is part of the National Institutes of Health (NIH), the principal biomedical and behavioral research agency of the United States Government. NIH is a component of the U.S. Department of Health and Human Services.

PDF documents require the free Adobe Reader. Microsoft Word documents require the free Microsoft Word viewer. Microsoft PowerPoint documents require the free Microsoft PowerPoint viewer. Flash content requires the free Adobe Flash Player.